BRIEF-Tango Therapeutics, BCTG Acquisition Corp. Announce Merger Agreement To Create Publicly Listed Precision Medicine Company Focused On Targeted Cancer Therapies

Reuters

Apr 14, 2021

April 14 (Reuters) - Bctg Acquisition Corp :

* TANGO THERAPEUTICS AND BCTG ACQUISITION CORP. ANNOUNCE MERGER AGREEMENT TO CREATE PUBLICLY LISTED PRECISION MEDICINE COMPANY FOCUSED ON THE NEXT GENERATION OF TARGETED CANCER THERAPIES

* BCTG ACQUISITION CORP - TOTAL PROCEEDS EXPECTED TO BE APPROXIMATELY $353 MILLION

* BCTG ACQUISITION - LEADING INSTITUTIONAL INVESTORS COMMIT $186 MILLION THROUGH A COMMON STOCK PRIVATE INVESTMENT IN PUBLIC EQUITY LED BY BOXER CAPITAL

* BCTG ACQUISITION CORP - TANGO THERAPEUTICS, INC. COMMON STOCK IS EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL "TNGX"

* BCTG ACQUISITION CORP - TOTAL PROCEEDS EXPECTED TO BE ABOUT $353 MILLION, COMBINING FUNDS HELD IN TRUST BY BCTG ACQUISITION CORP AND PIPE FINANCING

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2127902022"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2127902022\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2127902022?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-04-14 20:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2127902022","market":"us","top_or_hot":-1,"title":"BRIEF-Tango Therapeutics, BCTG Acquisition Corp. Announce Merger Agreement To Create Publicly Listed Precision Medicine Company Focused On Targeted Cancer Therapies","media":"Reuters","content":"<html><body><p>April 14 (Reuters) - Bctg Acquisition Corp   :</p><p>   * TANGO THERAPEUTICS AND BCTG ACQUISITION CORP. ANNOUNCE MERGER AGREEMENT TO CREATE PUBLICLY LISTED PRECISION MEDICINE COMPANY FOCUSED ON THE NEXT GENERATION OF TARGETED CANCER THERAPIES</p><p>   * BCTG ACQUISITION CORP - TOTAL PROCEEDS EXPECTED TO BE APPROXIMATELY $353 MILLION</p><p>   * BCTG ACQUISITION - LEADING INSTITUTIONAL INVESTORS COMMIT $186 MILLION THROUGH A COMMON STOCK PRIVATE INVESTMENT IN PUBLIC EQUITY LED BY BOXER CAPITAL</p><p>   * BCTG ACQUISITION CORP - TANGO THERAPEUTICS, INC. COMMON STOCK IS EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL \"TNGX\"</p><p>   * BCTG ACQUISITION CORP - TOTAL PROCEEDS EXPECTED TO BE ABOUT $353 MILLION, COMBINING FUNDS HELD IN TRUST BY BCTG ACQUISITION CORP AND PIPE FINANCING</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Tango Therapeutics, BCTG Acquisition Corp. Announce Merger Agreement To Create Publicly Listed Precision Medicine Company Focused On Targeted Cancer Therapies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Tango Therapeutics, BCTG Acquisition Corp. Announce Merger Agreement To Create Publicly Listed Precision Medicine Company Focused On Targeted Cancer Therapies\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-14 20:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>April 14 (Reuters) - Bctg Acquisition Corp   :</p><p>   * TANGO THERAPEUTICS AND BCTG ACQUISITION CORP. ANNOUNCE MERGER AGREEMENT TO CREATE PUBLICLY LISTED PRECISION MEDICINE COMPANY FOCUSED ON THE NEXT GENERATION OF TARGETED CANCER THERAPIES</p><p>   * BCTG ACQUISITION CORP - TOTAL PROCEEDS EXPECTED TO BE APPROXIMATELY $353 MILLION</p><p>   * BCTG ACQUISITION - LEADING INSTITUTIONAL INVESTORS COMMIT $186 MILLION THROUGH A COMMON STOCK PRIVATE INVESTMENT IN PUBLIC EQUITY LED BY BOXER CAPITAL</p><p>   * BCTG ACQUISITION CORP - TANGO THERAPEUTICS, INC. COMMON STOCK IS EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL \"TNGX\"</p><p>   * BCTG ACQUISITION CORP - TOTAL PROCEEDS EXPECTED TO BE ABOUT $353 MILLION, COMBINING FUNDS HELD IN TRUST BY BCTG ACQUISITION CORP AND PIPE FINANCING</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2127902022","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2127902022","pubTimestamp":1618404208,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"April 14  - Bctg Acquisition Corp   :   * TANGO THERAPEUTICS AND BCTG ACQUISITION CORP. ANNOUNCE MERGER AGREEMENT TO CREATE PUBLICLY LISTED PRECISION MEDICINE COMPANY FOCUSED ON THE NEXT GENERATION OF TARGETED CANCER THERAPIES   * BCTG ACQUISITION CORP - TOTAL PROCEEDS EXPECTED TO BE APPROXIMATELY $353 MILLION   * BCTG ACQUISITION - LEADING INSTITUTIONAL INVESTORS COMMIT $186 MILLION THROUGH A COMMON STOCK PRIVATE INVESTMENT IN PUBLIC EQUITY LED BY BOXER CAPITAL   * BCTG ACQUISITION CORP - TANGO","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Tango Therapeutics和BCTG Acquisition Corp.宣布合并协议，将创建专注于靶向癌症治疗的上市精准医疗公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BCTG":1},"content_text":"April 14 (Reuters) - Bctg Acquisition Corp   :   * TANGO THERAPEUTICS AND BCTG ACQUISITION CORP. ANNOUNCE MERGER AGREEMENT TO CREATE PUBLICLY LISTED PRECISION MEDICINE COMPANY FOCUSED ON THE NEXT GENERATION OF TARGETED CANCER THERAPIES   * BCTG ACQUISITION CORP - TOTAL PROCEEDS EXPECTED TO BE APPROXIMATELY $353 MILLION   * BCTG ACQUISITION - LEADING INSTITUTIONAL INVESTORS COMMIT $186 MILLION THROUGH A COMMON STOCK PRIVATE INVESTMENT IN PUBLIC EQUITY LED BY BOXER CAPITAL   * BCTG ACQUISITION CORP - TANGO THERAPEUTICS, INC. COMMON STOCK IS EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL \"TNGX\"   * BCTG ACQUISITION CORP - TOTAL PROCEEDS EXPECTED TO BE ABOUT $353 MILLION, COMBINING FUNDS HELD IN TRUST BY BCTG ACQUISITION CORP AND PIPE FINANCINGSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}